KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Neogenomics (NEO) over the last 15 years, with Sep 2025 value amounting to 0.51.

  • Neogenomics' Asset Utilization Ratio rose 30.60% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 30.60%. This contributed to the annual value of 0.40 for FY2024, which is 15.08% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Asset Utilization Ratio is 0.51, which was up 11.32% from 0.46 recorded in Q2 2025.
  • Neogenomics' 5-year Asset Utilization Ratio high stood at 0.60 for Q1 2021, and its period low was 0.25 during Q3 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.38 (2024), whereas its average is 0.39.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 71.46% in 2021, then soared by 30.60% in 2025.
  • Neogenomics' Asset Utilization Ratio (Quarterly) stood at 0.26 in 2021, then grew by 13.69% to 0.29 in 2022, then rose by 20.77% to 0.35 in 2023, then increased by 14.38% to 0.40 in 2024, then surged by 30.60% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q3 2025, 0.46 for Q2 2025, and 0.42 during Q1 2025.